Cédric Villain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cédric Villain has a total of 139 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Katrin Fietz
Institute of Biometry and Clinical Epidemiology, Charité – Universitätsmedizin Berlin , Berlin
2 shared publications Bérengère Beauplet
Normandie Univ, UNICAEN, INSERM ANTICIPE, U1086, Department of Geriatric Medicine, Centre Hospitalier Universitaire de Caen Normandie, Caen, France
2 shared publications- Elke Schaeffner
Institute of Public Health, Charité Universitätsmedizin Berlin, Berlin, Germany
2 shared publications - Muhammad Helmi Barghouth
Institute of Public Health, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany
2 shared publications - Natalie Ebert
Institute of Public Health, Charité Universitätsmedizin Berlin, Berlin, Germany
2 shared publications - Nina Mielke
Institute of Public Health, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin, Berlin, Germany
2 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by Wiley in Pain Practice
- Vol. 26 (8) , e70208
Pain Management in Older Adults: An Interprofessional Training Approach Assessed by Script Concordance Tests
Background: Optimal perioperative pain management in older adults challenges anesthesiologists due to increased drug sensitivity, altered pharmacokinetics, and limitations of pain assessment tools in cognitively impaired patients. This study evaluated whether a single 60‐min structured collaborative training session between a geriatrician and a clinical pharmacist is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by increased concordance with expert opinion on a script concordance test (SCT). Methods: SCT assessed 20 clinical vignettes covering pain assessment, analgesic selection, and adverse effect management domains. These were submitted to anesthesiologists before and after training. A panel of 13 geriatricians established scoring criteria. Internal consistency was measured using Cronbach's alpha. Paired t ‐tests and Wilcoxon signed‐rank tests compared pre‐ and post‐training scores, with the 95% confidence interval (CI) for the overall change estimated by bootstrap resampling. Results: Seventeen anesthesiologists completed both assessments. Mean SCT scores increased from 45.8 ± 7.4 to 59.5 ± 8.5 post‐training ( p < 0.001), showing a 29.7% improvement (95% CI, 18.7%–41.7%). Analysis revealed improvements in analgesic prescription (+47.9%; 95% CI, 10.0–28.1 points) and adverse effect management (+26.8%; 95% CI, 9.1–19.0 points), while the change in pain assessment was not statistically significant (−11.6%; 95% CI, −16.6–9.4 points). Internal consistency improved from 0.542 to 0.704. Most participants (89.5%) lacked prior training in prescribing analgesics to older adults, and 73.7% were unfamiliar with clinical guidelines. Conclusion: This study suggests that collaborative geriatrician‐pharmacist training is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by greater concordance with expert opinion on a script concordance test. The varying effects across domains suggest that distinct competencies may require distinct educational approaches. These findings support further investigation of interprofessional education into anesthesiology training to enhance clinical reasoning in the care of older surgical patients.
- 3 October 2026
- Published by Wiley in Pain Practice
- Vol. 26 (8) , e70208
Open AccessPain Management in Older Adults: An Interprofessional Training Approach Assessed by Script Concordance Tests
Background: Optimal perioperative pain management in older adults challenges anesthesiologists due to increased drug sensitivity, altered pharmacokinetics, and limitations of pain assessment tools in cognitively impaired patients. This study evaluated whether a single 60‐min structured collaborative training session between a geriatrician and a clinical pharmacist is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by increased concordance with expert opinion on a script concordance test (SCT). Methods: SCT assessed 20 clinical vignettes covering pain assessment, analgesic selection, and adverse effect management domains. These were submitted to anesthesiologists before and after training. A panel of 13 geriatricians established scoring criteria. Internal consistency was measured using Cronbach's alpha. Paired t ‐tests and Wilcoxon signed‐rank tests compared pre‐ and post‐training scores, with the 95% confidence interval (CI) for the overall change estimated by bootstrap resampling. Results: Seventeen anesthesiologists completed both assessments. Mean SCT scores increased from 45.8 ± 7.4 to 59.5 ± 8.5 post‐training ( p < 0.001), showing a 29.7% improvement (95% CI, 18.7%–41.7%). Analysis revealed improvements in analgesic prescription (+47.9%; 95% CI, 10.0–28.1 points) and adverse effect management (+26.8%; 95% CI, 9.1–19.0 points), while the change in pain assessment was not statistically significant (−11.6%; 95% CI, −16.6–9.4 points). Internal consistency improved from 0.542 to 0.704. Most participants (89.5%) lacked prior training in prescribing analgesics to older adults, and 73.7% were unfamiliar with clinical guidelines. Conclusion: This study suggests that collaborative geriatrician‐pharmacist training is associated with improved anesthesiologists' clinical reasoning regarding perioperative analgesic management in older adults, as measured by greater concordance with expert opinion on a script concordance test. The varying effects across domains suggest that distinct competencies may require distinct educational approaches. These findings support further investigation of interprofessional education into anesthesiology training to enhance clinical reasoning in the care of older surgical patients.
- 28 July 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
Long-term results of a multidisciplinary medication optimization program for older adults including primary care and hospital team
Therapeutic optimization and deprescribing in older adults face multiple barriers, whereas drug-related hospitalization increased from 3.6% to 8.5% between 2006 and 2018. The OPTIMEDOC program aims to optimize older adults' prescriptions through clinical medication review conducted by a multidisciplinary team including clinical pharmacist, geriatrician, and general practitioner (GP). This collaboration between primary care and hospital team aims to enable appropriate and sustainable prescriptions. This study aimed to assess the implementation of therapeutic optimizations at least 6 months after the intervention. The secondary objective was to document the most frequently deprescribed and newly introduced medications and their long-term implementation rate. This observational study was conducted in a university hospital, including patients who benefited from the OPTIMEDOC program from April 2022 to April 2024. The primary outcome was the long-term implementation rate of recommendations. The secondary outcome was a description of the optimized drugs according to ATC2 classes. Among 1580 validated therapeutic recommendations for 143 patients included with an average age of 86.4 years old, 1473 were followed up (93.2%). Of these, 1017 were successfully implemented over 1 year (69.0%). Specifically, 81.8% of deprescriptions, 58.3% of introductions, and 70.5% of modifications were implemented. Although vaccine introductions were the most frequently recommended (n = 222), only 41% were implemented. Regarding deprescribing, psycholeptics, psychoanaleptics, and drugs for acid-related disorders had a long-term implementation rate of over 75%. These results validate the OPTIMEDOC program as an effective strategy for sustainable therapeutic optimization, especially for deprescribing. Engaging community pharmacists could further enhance the implementation of therapeutic recommendations.
- 28 July 2025
- Published by Springer Nature in European Journal of Clinical Pharmacology
Long-term results of a multidisciplinary medication optimization program for older adults including primary care and hospital team
Therapeutic optimization and deprescribing in older adults face multiple barriers, whereas drug-related hospitalization increased from 3.6% to 8.5% between 2006 and 2018. The OPTIMEDOC program aims to optimize older adults' prescriptions through clinical medication review conducted by a multidisciplinary team including clinical pharmacist, geriatrician, and general practitioner (GP). This collaboration between primary care and hospital team aims to enable appropriate and sustainable prescriptions. This study aimed to assess the implementation of therapeutic optimizations at least 6 months after the intervention. The secondary objective was to document the most frequently deprescribed and newly introduced medications and their long-term implementation rate. This observational study was conducted in a university hospital, including patients who benefited from the OPTIMEDOC program from April 2022 to April 2024. The primary outcome was the long-term implementation rate of recommendations. The secondary outcome was a description of the optimized drugs according to ATC2 classes. Among 1580 validated therapeutic recommendations for 143 patients included with an average age of 86.4 years old, 1473 were followed up (93.2%). Of these, 1017 were successfully implemented over 1 year (69.0%). Specifically, 81.8% of deprescriptions, 58.3% of introductions, and 70.5% of modifications were implemented. Although vaccine introductions were the most frequently recommended (n = 222), only 41% were implemented. Regarding deprescribing, psycholeptics, psychoanaleptics, and drugs for acid-related disorders had a long-term implementation rate of over 75%. These results validate the OPTIMEDOC program as an effective strategy for sustainable therapeutic optimization, especially for deprescribing. Engaging community pharmacists could further enhance the implementation of therapeutic recommendations.
- 25 March 2025
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 134, 105836
Advance care planning procedure in older patients at a high risk of death after discharge from the acute geriatric unit: A study protocol
- 25 March 2025
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 134, 105836
Advance care planning procedure in older patients at a high risk of death after discharge from the acute geriatric unit: A study protocol
- Open Access
Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase
Objectives Proton pump inhibitor (PPI) exposure can lead to hyponatraemia, which is a common cause of delirium. An association between PPI exposure and delirium without hyponatraemia has been suggested in the literature. We aimed to describe the association between reports of delirium and PPI exposure and to assess the association between PPI and delirium with and without hyponatraemia. Design A descriptive and disproportionality analysis of claims data. Setting World pharmacovigilance database VigiBase between 1 January 1991 and 9 February 2022. Primary and secondary outcome measures In the first part, we described reports of delirium for which involvement of a PPI or interactions of PPIs with other drugs were suspected. In the second part, delirium cases and non-cases were used to assess the disproportionality signal using the reporting OR (ROR) for the associations of PPI exposure with delirium or delirium/hyponatraemia co-events. Results We identified 2395 reports of delirium in which involvement of PPI exposure was suspected. Omeprazole, esomeprazole and pantoprazole were the most frequently reported PPIs. Hyponatraemia was present in 11% of the reports. The disproportionality analysis included 1 264 798 reports of adverse drug reactions in patients using PPIs, including 19 081 reports of delirium. We did not find a disproportionality signal for the association between PPI use and delirium (ROR 0.89, 95% CI 0.87 to 0.91). We detected an association of PPI use with delirium/hyponatraemia co-events (ROR 1.53, 95% CI 1.41 to 1.65). Conclusions Most reports of delirium in which the involvement of PPIs was suspected did not include concomitant hyponatraemia. However, no significant signal of disproportionate reporting of delirium was observed for PPIs compared with other drugs, except in cases of delirium associated with hyponatraemia. Hyponatraemia may be the main mechanism linking PPI exposure with delirium, and this possibility should be further explored in prospective studies. Trial registration number NCT05815550.
Open AccessAssociation between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase
Objectives Proton pump inhibitor (PPI) exposure can lead to hyponatraemia, which is a common cause of delirium. An association between PPI exposure and delirium without hyponatraemia has been suggested in the literature. We aimed to describe the association between reports of delirium and PPI exposure and to assess the association between PPI and delirium with and without hyponatraemia. Design A descriptive and disproportionality analysis of claims data. Setting World pharmacovigilance database VigiBase between 1 January 1991 and 9 February 2022. Primary and secondary outcome measures In the first part, we described reports of delirium for which involvement of a PPI or interactions of PPIs with other drugs were suspected. In the second part, delirium cases and non-cases were used to assess the disproportionality signal using the reporting OR (ROR) for the associations of PPI exposure with delirium or delirium/hyponatraemia co-events. Results We identified 2395 reports of delirium in which involvement of PPI exposure was suspected. Omeprazole, esomeprazole and pantoprazole were the most frequently reported PPIs. Hyponatraemia was present in 11% of the reports. The disproportionality analysis included 1 264 798 reports of adverse drug reactions in patients using PPIs, including 19 081 reports of delirium. We did not find a disproportionality signal for the association between PPI use and delirium (ROR 0.89, 95% CI 0.87 to 0.91). We detected an association of PPI use with delirium/hyponatraemia co-events (ROR 1.53, 95% CI 1.41 to 1.65). Conclusions Most reports of delirium in which the involvement of PPIs was suspected did not include concomitant hyponatraemia. However, no significant signal of disproportionate reporting of delirium was observed for PPIs compared with other drugs, except in cases of delirium associated with hyponatraemia. Hyponatraemia may be the main mechanism linking PPI exposure with delirium, and this possibility should be further explored in prospective studies. Trial registration number NCT05815550.
- Open Access
- 12 April 2024
- Published by Springer Nature in BMC Geriatrics
- Vol. 24 (1) , 1-11
Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults
Background: Frailty and polypharmacy are common conditions in older adults, especially in those with chronic kidney disease (CKD). Therefore, we analyzed the association of polypharmacy and incident frailty and the effect modification by CKD in very old adults. Methods: In non-frail individuals within the Berlin Initiative (cohort) Study, polypharmacy (≥ 5 medications) was assessed according to multiple definitions based on the number of regular and on demand prescription and over the counter drugs, as well as vitamins and supplements. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73m2 and/or an albumin-creatinine ratio ≥ 30 mg/g. Incident frailty was assessed at follow-up using Fried criteria. Logistic regression was applied to assess (1) the association of different polypharmacy definitions with incident frailty and (2) effect modification by CKD. Results: In this cohort study, out of 757 non-frail participants (mean age 82.9 years, 52% female, 74% CKD), 298 (39%) participants reported polypharmacy. Over the observation period of 2.1 years, 105 became frail. Individuals with polypharmacy had 1.96 adjusted odds (95% confidence interval (CI): 1.20–3.19) of becoming frail compared to participants without polypharmacy. The effect of polypharmacy on incident frailty was modified by CKD on the additive scale (relative excess risk due to interaction: 1.56; 95% CI 0.01–3.12). Conclusions: This study demonstrates an association of polypharmacy and incident frailty and suggests strong evidence for an effect modification of CKD on polypharmacy and incident frailty. Revision of prescriptions could be a target strategy to prevent frailty occurrence, especially in older adults with CKD.
- 12 April 2024
- Published by Springer Nature in BMC Geriatrics
- Vol. 24 (1) , 1-11
Open AccessEffect modification of polypharmacy on incident frailty by chronic kidney disease in older adults
Background: Frailty and polypharmacy are common conditions in older adults, especially in those with chronic kidney disease (CKD). Therefore, we analyzed the association of polypharmacy and incident frailty and the effect modification by CKD in very old adults. Methods: In non-frail individuals within the Berlin Initiative (cohort) Study, polypharmacy (≥ 5 medications) was assessed according to multiple definitions based on the number of regular and on demand prescription and over the counter drugs, as well as vitamins and supplements. CKD was defined as an estimated glomerular filtration rate < 60 mL/min/1.73m2 and/or an albumin-creatinine ratio ≥ 30 mg/g. Incident frailty was assessed at follow-up using Fried criteria. Logistic regression was applied to assess (1) the association of different polypharmacy definitions with incident frailty and (2) effect modification by CKD. Results: In this cohort study, out of 757 non-frail participants (mean age 82.9 years, 52% female, 74% CKD), 298 (39%) participants reported polypharmacy. Over the observation period of 2.1 years, 105 became frail. Individuals with polypharmacy had 1.96 adjusted odds (95% confidence interval (CI): 1.20–3.19) of becoming frail compared to participants without polypharmacy. The effect of polypharmacy on incident frailty was modified by CKD on the additive scale (relative excess risk due to interaction: 1.56; 95% CI 0.01–3.12). Conclusions: This study demonstrates an association of polypharmacy and incident frailty and suggests strong evidence for an effect modification of CKD on polypharmacy and incident frailty. Revision of prescriptions could be a target strategy to prevent frailty occurrence, especially in older adults with CKD.
- 25 October 2023
- Published by Springer Nature in Drugs & Aging
- Vol. 41 (2) , 125-139
NSAIDs for Pain Control During the Peri-Operative Period of Hip Fracture Surgery: A Systematic Review
Background Hip fracture (HF) mostly affects older adults and is responsible for increased morbidity and mortality. Non-steroidal anti-inflammatory drugs (NSAIDs) are part of the peri-operative multimodal analgesic management, but their use could be associated with adverse events in older adults. This systematic review aimed to assess outcomes associated with NSAIDs use in the peri-operative period of HF surgery. Methods This systematic review was conducted according to the PRISMA guidelines. Three databases (PubMed/EMBASE/Cochrane Central) were used to search for clinical trials and observational studies assessing efficacy, safety and impact of NSAIDs use on non-specific post-operative outcomes, such as functional status and post-operative complications. Results Among the 1320 references initially identified, four provided data on efficacy, four on safety and six on non-specific post-operative outcomes (three randomized controlled clinical trials, three observational studies). Mean study population ages ranged from 68 to 87 years. Two studies found that NSAIDs were effective on pain control, but two studies found conflicting results on opioid sparing. No increased risk of acute kidney injury was observed, while results concerning bleeding risk and delirium were conflicting. No study has found any effect of NSAIDs use on walk recovery. Quality of evidence was high for pain control, but low to very low for all the other studied outcomes. Conclusions The use of NSAIDs may be effective for pain control in the peri-operative period of HF surgery. However, safety data were conflicting with low levels of certainty. Further studies are needed to assess their benefit–risk balance in this context. The research protocol was previously registered on PROSPERO (registration number: CRD42021237649)
- 25 October 2023
- Published by Springer Nature in Drugs & Aging
- Vol. 41 (2) , 125-139
NSAIDs for Pain Control During the Peri-Operative Period of Hip Fracture Surgery: A Systematic Review
Background Hip fracture (HF) mostly affects older adults and is responsible for increased morbidity and mortality. Non-steroidal anti-inflammatory drugs (NSAIDs) are part of the peri-operative multimodal analgesic management, but their use could be associated with adverse events in older adults. This systematic review aimed to assess outcomes associated with NSAIDs use in the peri-operative period of HF surgery. Methods This systematic review was conducted according to the PRISMA guidelines. Three databases (PubMed/EMBASE/Cochrane Central) were used to search for clinical trials and observational studies assessing efficacy, safety and impact of NSAIDs use on non-specific post-operative outcomes, such as functional status and post-operative complications. Results Among the 1320 references initially identified, four provided data on efficacy, four on safety and six on non-specific post-operative outcomes (three randomized controlled clinical trials, three observational studies). Mean study population ages ranged from 68 to 87 years. Two studies found that NSAIDs were effective on pain control, but two studies found conflicting results on opioid sparing. No increased risk of acute kidney injury was observed, while results concerning bleeding risk and delirium were conflicting. No study has found any effect of NSAIDs use on walk recovery. Quality of evidence was high for pain control, but low to very low for all the other studied outcomes. Conclusions The use of NSAIDs may be effective for pain control in the peri-operative period of HF surgery. However, safety data were conflicting with low levels of certainty. Further studies are needed to assess their benefit–risk balance in this context. The research protocol was previously registered on PROSPERO (registration number: CRD42021237649)
- Open Access
- 4 September 2023
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 16 (12) , 2661-2671
Kidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation
The Cockcroft-Gault equation (CrClC-G) is recommended for dose adjustment of direct oral anticoagulant drugs (DOACs) to kidney function. We aimed to assess whether defining DOACs dose appropriateness according to various kidney function estimators changed the associations between dose appropriateness and adverse events in older adults with atrial fibrillation (AF). Participants of the Berlin Initiative Study with AF and treated with DOACs were included. We investigated CrClC-G and estimated glomerular filtration rate (eGFR) using CKD-EPI and EKFC equations based on creatinine and/or cystatin C. Marginal structural Cox models yielded confounder-adjusted hazard ratios for the risk of mortality, thromboembolism, and bleeding associated with dose status. 224 patients were included in the analysis (median age 87 years). Using CrClC-G, 154 (69%) had appropriate dose of DOACs, 52 (23%) were underdosed, and 18 (8%) were overdosed. During a 39-month median follow-up period, 109 (14.9/100 person-years) participants died, 25 (3.6/100 person-years) experienced thromboembolism, and 60 (9.8/100 person-years) bleeding. Dose status was not associated with mortality and thromboembolism, independent of the equation. Underdose status was associated with a lower risk of bleeding with all the equations, compared to the appropriate dose group. In participants with discrepancies in dose status using CrClC-G and eGFR equations, the occurrence of endpoints did not differ between participants having appropriate dose using CrClC-G or eGFR. In older adults with AF, the association of DOACs dose status with adverse events did not differ when using CrClC-G or eGFR. Our results suggest that eGFR equations are not inferior to CrClC-G within this context.
- 4 September 2023
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 16 (12) , 2661-2671
Open AccessKidney function estimators for drug dose adjustment of direct oral anticoagulants in older adults with atrial fibrillation
The Cockcroft-Gault equation (CrClC-G) is recommended for dose adjustment of direct oral anticoagulant drugs (DOACs) to kidney function. We aimed to assess whether defining DOACs dose appropriateness according to various kidney function estimators changed the associations between dose appropriateness and adverse events in older adults with atrial fibrillation (AF). Participants of the Berlin Initiative Study with AF and treated with DOACs were included. We investigated CrClC-G and estimated glomerular filtration rate (eGFR) using CKD-EPI and EKFC equations based on creatinine and/or cystatin C. Marginal structural Cox models yielded confounder-adjusted hazard ratios for the risk of mortality, thromboembolism, and bleeding associated with dose status. 224 patients were included in the analysis (median age 87 years). Using CrClC-G, 154 (69%) had appropriate dose of DOACs, 52 (23%) were underdosed, and 18 (8%) were overdosed. During a 39-month median follow-up period, 109 (14.9/100 person-years) participants died, 25 (3.6/100 person-years) experienced thromboembolism, and 60 (9.8/100 person-years) bleeding. Dose status was not associated with mortality and thromboembolism, independent of the equation. Underdose status was associated with a lower risk of bleeding with all the equations, compared to the appropriate dose group. In participants with discrepancies in dose status using CrClC-G and eGFR equations, the occurrence of endpoints did not differ between participants having appropriate dose using CrClC-G or eGFR. In older adults with AF, the association of DOACs dose status with adverse events did not differ when using CrClC-G or eGFR. Our results suggest that eGFR equations are not inferior to CrClC-G within this context.
- 14 August 2023
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 78 (12) , 2458-2465
Gripwise Versus Jamar: The Challenge of a New Dynamometer Assessing Handgrip Strength
Background: Sarcopenia diagnosis is partly based on handgrip strength (HGS) assessment. The gold-standard dynamometer for this measurement is the Jamar. The electronic Gripwise is a smaller and lighter one, and its measurements are correlated with the Jamar’s in laboratory tests. Our study aimed to confirm this correlation in aged patients. Methods: This monocenter cross-sectional study was performed in patients of 65 years and older admitted at the University Hospital. Participants were assessed either in a seated or bedridden position, randomly allocated to begin the measurements with the Jamar or the Gripwise. Results: Among 649 aged inpatients assessed for eligibility, 348 were included (mean age: 79 ± 9; 52% females). The intraclass correlation coefficient was 0.93 (95% confidence interval [CI] 0.92–0.94, p < .001) for the maximum value measured with both devices and 0.94 (95% CI 0.93–0.95, p < .001) for the mean values. However, there was a significant difference in detecting low values (<16 kg in women, <27 kg in men), found in 48% of patients with Jamar, and 71% with Gripwise (p < .001). Thus, we determined alternate cutoffs for diagnosing HGS low values with the Gripwise (<12 kg in women, <22 kg in men), further validated in a supplementary validation population (n = 70). The diagnostic performances of these alternative cutoffs were high (93% sensitivity and 87% specificity in women; 94% sensitivity and 96% specificity in men). Conclusions: The correlation of the Gripwise with the Jamar was confirmed in aged inpatients. However, lower values recorded with the Gripwise require alternate cutoffs for a relevant low HGS diagnosis.
- 14 August 2023
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 78 (12) , 2458-2465
Gripwise Versus Jamar: The Challenge of a New Dynamometer Assessing Handgrip Strength
Background: Sarcopenia diagnosis is partly based on handgrip strength (HGS) assessment. The gold-standard dynamometer for this measurement is the Jamar. The electronic Gripwise is a smaller and lighter one, and its measurements are correlated with the Jamar’s in laboratory tests. Our study aimed to confirm this correlation in aged patients. Methods: This monocenter cross-sectional study was performed in patients of 65 years and older admitted at the University Hospital. Participants were assessed either in a seated or bedridden position, randomly allocated to begin the measurements with the Jamar or the Gripwise. Results: Among 649 aged inpatients assessed for eligibility, 348 were included (mean age: 79 ± 9; 52% females). The intraclass correlation coefficient was 0.93 (95% confidence interval [CI] 0.92–0.94, p < .001) for the maximum value measured with both devices and 0.94 (95% CI 0.93–0.95, p < .001) for the mean values. However, there was a significant difference in detecting low values (<16 kg in women, <27 kg in men), found in 48% of patients with Jamar, and 71% with Gripwise (p < .001). Thus, we determined alternate cutoffs for diagnosing HGS low values with the Gripwise (<12 kg in women, <22 kg in men), further validated in a supplementary validation population (n = 70). The diagnostic performances of these alternative cutoffs were high (93% sensitivity and 87% specificity in women; 94% sensitivity and 96% specificity in men). Conclusions: The correlation of the Gripwise with the Jamar was confirmed in aged inpatients. However, lower values recorded with the Gripwise require alternate cutoffs for a relevant low HGS diagnosis.
- Open Access
- 3 January 2023
- Published by EDP Sciences in Pédagogie Médicale
- Vol. 24 (1) , 51-59
Mini-entretiens multiples : un outil pour la réforme de l’accès aux études en santé en France
Introduction : Depuis la loi de santé de 2019, les modalités d’accès aux études en maïeutique, médecine, odontologie et pharmacie comportent des épreuves écrites et, pour une partie des étudiants, au moins une épreuve orale. Les mini-entretiens multiples (MEM) permettent d’évaluer les capacités de communication, l’empathie ou les capacités de travail en groupe et sont moins biaisés que les entretiens individuels traditionnels. Cet article propose une revue narrative de la littérature afin d’évaluer la faisabilité des MEM dans le contexte français. Méthodes : Cet article de synthèse s’appuie sur une recherche bibliographique à partir de la base PubMed avec le mot clé « Multiple Mini Interview ». Les articles sélectionnés devaient traiter au moins une des questions suivantes relatives aux MEM : organisation, acceptabilité, compétences évaluées, prédiction des performances. Résultats : Les MEM ont été utilisés pour la sélection des candidats à de nombreuses filières en santé et dans de nombreux pays. Les résultats obtenus aux MEM à l’admission sont corrélés aux performances obtenues lors des stages cliniques et des ECOS durant le cursus universitaire. Cependant, certaines caractéristiques des candidats peuvent influer les résultats obtenus (âge, facteurs socio-économiques) et les MEM mobilisent de nombreux évaluateurs pour leur mise en œuvre. Conclusion : Les MEM sont une modalité d’évaluation reproductible et validée pour la sélection des étudiants en santé, en complément de l’évaluation des aptitudes cognitives. Ils devraient être largement utilisés pour la sélection des étudiants en santé en France, depuis la réforme de l’accès aux études en santé. Context and background: Since the 2019 Health Legislation in France, admission into programs of midwifery, medicine, dentistry and pharmacy require a written examination and, for a portion of students, at least one oral examination. Multiple Mini-Interviews (MMI) allow for the assessment of communication skills, empathy or group work skills and are less biased than traditional individual interviews. This article proposes a narrative review of the literature to assess the feasibility of MMI in the French context. Methods: This narrative review article was based on a PubMed database research using the keyword “Multiple Mini Interview”. The selected articles had to deal with at least one of the following issues related to the MM: organization, acceptability, skills assessed, and performance prediction. Results: The MMI have been used in the selection of candidates for many health professions and in many countries. The results obtained from the MMI used for admission are correlated with the performances obtained during the clinical internships and the OSCEs during the training curriculum. However, certain characteristics of the candidates may influence the results obtained (e.g. age, socioeconomic factors) and the MMI mobilize many evaluators for their implementation. Conclusion: The MMI is a reproducible and validated assessment modality for the selection of health science students, in addition to the assessment of cognitive skills by written exams. They should be widely used for the selection of health students in France, since the reform of access to health studies.
- 3 January 2023
- Published by EDP Sciences in Pédagogie Médicale
- Vol. 24 (1) , 51-59
Open AccessMini-entretiens multiples : un outil pour la réforme de l’accès aux études en santé en France
Introduction : Depuis la loi de santé de 2019, les modalités d’accès aux études en maïeutique, médecine, odontologie et pharmacie comportent des épreuves écrites et, pour une partie des étudiants, au moins une épreuve orale. Les mini-entretiens multiples (MEM) permettent d’évaluer les capacités de communication, l’empathie ou les capacités de travail en groupe et sont moins biaisés que les entretiens individuels traditionnels. Cet article propose une revue narrative de la littérature afin d’évaluer la faisabilité des MEM dans le contexte français. Méthodes : Cet article de synthèse s’appuie sur une recherche bibliographique à partir de la base PubMed avec le mot clé « Multiple Mini Interview ». Les articles sélectionnés devaient traiter au moins une des questions suivantes relatives aux MEM : organisation, acceptabilité, compétences évaluées, prédiction des performances. Résultats : Les MEM ont été utilisés pour la sélection des candidats à de nombreuses filières en santé et dans de nombreux pays. Les résultats obtenus aux MEM à l’admission sont corrélés aux performances obtenues lors des stages cliniques et des ECOS durant le cursus universitaire. Cependant, certaines caractéristiques des candidats peuvent influer les résultats obtenus (âge, facteurs socio-économiques) et les MEM mobilisent de nombreux évaluateurs pour leur mise en œuvre. Conclusion : Les MEM sont une modalité d’évaluation reproductible et validée pour la sélection des étudiants en santé, en complément de l’évaluation des aptitudes cognitives. Ils devraient être largement utilisés pour la sélection des étudiants en santé en France, depuis la réforme de l’accès aux études en santé. Context and background: Since the 2019 Health Legislation in France, admission into programs of midwifery, medicine, dentistry and pharmacy require a written examination and, for a portion of students, at least one oral examination. Multiple Mini-Interviews (MMI) allow for the assessment of communication skills, empathy or group work skills and are less biased than traditional individual interviews. This article proposes a narrative review of the literature to assess the feasibility of MMI in the French context. Methods: This narrative review article was based on a PubMed database research using the keyword “Multiple Mini Interview”. The selected articles had to deal with at least one of the following issues related to the MM: organization, acceptability, skills assessed, and performance prediction. Results: The MMI have been used in the selection of candidates for many health professions and in many countries. The results obtained from the MMI used for admission are correlated with the performances obtained during the clinical internships and the OSCEs during the training curriculum. However, certain characteristics of the candidates may influence the results obtained (e.g. age, socioeconomic factors) and the MMI mobilize many evaluators for their implementation. Conclusion: The MMI is a reproducible and validated assessment modality for the selection of health science students, in addition to the assessment of cognitive skills by written exams. They should be widely used for the selection of health students in France, since the reform of access to health studies.
- 1 June 2022
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 23 (6) , 998-1004.e7
Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease
- 1 June 2022
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 23 (6) , 998-1004.e7
Effectiveness and Tolerance of Renin-Angiotensin System Inhibitors With Aging in Chronic Kidney Disease